Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate.

Oncotarget · 2019 · PMC6343754 · PMID 30713600

Europe PMC DOI

hedged sentences

0.0640

closest p · 1.3× alpha

0.1140

boldest claim

The sentences

a strong trendp=0.064so close (0.05 < p ≤ 0.1)

Patients with elevated levels of lactate dehydrogenase (LDH) showed a strong trend towards a shortened OS of 5.4 vs. 17.3 months (p=0.064).

also in 5,725 other papers

showed a trendp=0.114not close (p > 0.1)

Patients primarily treated with carboplatin showed a trend towards a prolonged PFS of 7.5 months vs. those receiving cisplatin (3.9 months, p=0.114) (Figure 3A ).

also in 53,322 other papers

a slight trendno p-value reported

However, in our study there was a slight trend for a prolonged PFS with carboplatin.

also in 4,078 other papers

failed to reach significanceno p-value reported

Patients with a lower Ki67 of < 55 % showed a strong trend for a shortened PFS under PE, this difference failed to reach significance most likely due to the small patient numbers in this group.

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.